{"id":26695,"date":"2021-09-19T15:13:13","date_gmt":"2021-09-19T13:13:13","guid":{"rendered":"https:\/\/www.transgene.com\/?p=26695"},"modified":"2025-12-15T23:08:10","modified_gmt":"2025-12-15T22:08:10","slug":"james-wentworth-phd","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/james-wentworth-phd\/","title":{"rendered":"James Wentworth, PhD"},"content":{"rendered":"\n<p><img decoding=\"async\" class=\"imgMembers wp-image-29727 size-medium aligncenter\" src=\"..\/..\/wp-content\/uploads\/25-12-18-Transgene-0179-\u00a9-Bartosch-Salmanski.jpg\" alt=\"\"><\/p>\n<p>James Wentworth occupe le poste de Directeur Business Development depuis 2024. James Wentworth est en charge de la d\u00e9finition, de la supervision et de la mise en \u0153uvre de la strat\u00e9gie de Business Development de Transgene, les affaires commerciales, ainsi que de la strat\u00e9gie partenariale.<\/p>\n<p>James Wentworth a plus de quinze ans d\u2019exp\u00e9rience dans l\u2019industrie pharmaceutique et la biotechnologie. Auparavant, James \u00e9tait Directeur du Business Development et de la Strat\u00e9gie chez Adaptimmune, une soci\u00e9t\u00e9 de biotechnologie cot\u00e9e au NASDAQ, sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de th\u00e9rapies cellulaires bas\u00e9es sur les r\u00e9cepteurs des cellules T (TCR) pour les tumeurs solides. Il \u00e9tait alors responsable de la gestion des partenariats pharmaceutiques, des collaborations et transactions, des projets de d\u00e9veloppement d\u2019entreprise et du d\u00e9veloppement de la strat\u00e9gie commerciale. Il a \u00e9galement dirig\u00e9 le d\u00e9partement de veille concurrentielle. Pr\u00e9c\u00e9demment, James a travaill\u00e9 avec des soci\u00e9t\u00e9s de biotechnologie au stade de d\u00e9veloppement chez inVentiv Health (aujourd\u2019hui Syneos Health), chez Shire, en contribuant au d\u00e9veloppement de produits \u00e0 la suite d\u2019une fusion-acquisition. Il a \u00e9galement g\u00e9r\u00e9 des lancements commerciaux sur les march\u00e9s europ\u00e9ens pour ViroPharma Europe.<\/p>\n<p>James est titulaire d\u2019une licence et d\u2019un doctorat en pharmacologie de l\u2019Universit\u00e9 de Bristol ainsi que d\u2019un MBA de l\u2019International Institute for Management Development (IMD), \u00e0 Lausanne (Suisse).<\/p>\n<p>&nbsp;<\/p>\n<div class=\"LienIn\"><a href=\"https:\/\/www.linkedin.com\/in\/james-wentworth-phd-mba-1120104\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-25981\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/in.svg\" alt=\"\" width=\"30\" height=\"30\"><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>James Wentworth occupe le poste de Directeur Business Development depuis 2024. James Wentworth est en charge de la d\u00e9finition, de la supervision et de la mise en \u0153uvre de la strat\u00e9gie de Business Development de Transgene, les affaires commerciales, ainsi que de la strat\u00e9gie partenariale. James Wentworth a plus de quinze ans d\u2019exp\u00e9rience dans l\u2019industrie&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/james-wentworth-phd\/\">Poursuivre la lecture <span class=\"screen-reader-text\">James Wentworth, PhD<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[111],"tags":[],"class_list":["post-26695","post","type-post","status-publish","format-standard","hentry","category-outils-profils","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"James Wentworth occupe le poste de Directeur Business Development depuis 2024. James Wentworth est en charge de la d\u00e9finition, de la supervision et de la mise en \u0153uvre de la strat\u00e9gie de Business Development de Transgene, les affaires commerciales, ainsi que de la strat\u00e9gie partenariale. James Wentworth a plus de quinze ans d\u2019exp\u00e9rience dans l\u2019industrie&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=26695"}],"version-history":[{"count":7,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26695\/revisions"}],"predecessor-version":[{"id":39535,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26695\/revisions\/39535"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=26695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=26695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=26695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}